MIMICH II
Research type
Research Study
Full title
Metformin Impact on Maternal and Infant Cardiometabolic Health After Pregnancy
IRAS ID
306466
Contact name
Jenny Myers
Contact email
Sponsor organisation
The University of Manchester
ISRCTN Number
ISRCTN13866189
Duration of Study in the UK
3 years, 11 months, 31 days
Research summary
MIMICH II is the follow up study to MIMICH trial, and will recruit the mothers who took part in MIMICH and their children to answer the questions: (1) In infants born to women with poor cardiometabolic health, what is the impact of metformin on early postnatal growth and metabolic function? (2) does maternal exposure to metformin during pregnancy improve maternal cardiometabolic health status 1 year after pregnancy? \n\nThe research will comprise of two study visits at 3 - 6 months and 1 year; where physical measurements (height, weight & skinfold thickness) will be taken from the mother and baby, along with fasting research blood samples from the mother at both visits, and the babies at the 1 year visit (with parental consent).
REC name
South Central - Oxford B Research Ethics Committee
REC reference
22/SC/0037
Date of REC Opinion
1 Feb 2022
REC opinion
Further Information Favourable Opinion